Time-to-event assessment for the discovery of the proper prognostic value of clinical biomarkers optimized for COVID-19. Clinics [Internet]. 2022 Feb. 4 [cited 2024 Jun. 15];77:100009. Available from: https://www.journals.usp.br/clinics/article/view/213626